🌎 🌍 Meet the Trailhead teams this October at multiple conferences! Our team will be attending ISSCR – Copenhagen Symposium 2024, Neuroscience2024, and Meeting on the Mesa 2024! 🤝 Connect with us at these meetings to learn about our iPSC-derived human cell portfolio and how we implement our High-Dimensional Design of Experiments (HD-DoE®) for developing protocols. https://trailbio.com/ #TrailBio #TrailBioCells #Trailblazing #trailheadbiosystems #hddoe #stemcells #ipsc #ipscs #cellbiology #stemcellinnovation #neuroscience #cellculture #hematopoeitic #sfn2024 #neuroscience2024 #isscr
Trailhead Biosystems
Biotechnology Research
Cleveland, OH 3,806 followers
Morally obligated to deliver cells you can trust.
About us
Trailhead Biosystems merges developmental biology and cell therapeutics with cutting edge hardware, and computerized experimental design and analysis to perform process-specific parameter optimization for customers seeking to develop cell therapies. Implementing Quality by Design (QbD) principles, cell culture optimization is done by utilizing Design of Experiment (DoE) theory combined with Multivariate Data Analysis (MVDA). This allows Trailhead to generate mathematical models of the biological system, understand the effector-response relationship in cell culture, and provide a systems biology analysis of the differentiation space. DoE-based experimental design and robotic execution greatly reduce the number of experiments and time needed for optimizing a large number of variables simultaneously. You will see that Trailhead Biosystems is novel from its ability to: Have computer-based experimental designs executed for advanced cell culture Gain knowledge into how cell culture affects gene expression in cells Mathematically model the effector/response space so virtual experiments can be performed and enable exploration of cell biology to predict how additives will create desirable cell culture fates Address optimization challenges for cell purity and potency Understand the variance in cell manufacturing methods
- Website
-
http://www.trailbio.com
External link for Trailhead Biosystems
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Cleveland, OH
- Type
- Privately Held
- Founded
- 2015
- Specialties
- Cell Culture Optimization, Mathematical Modeling, Stem Cell Differentiation, Systems Developmental Biology, Big Data 2 Knowledge (BD2K), Morphogens and Growth Factors, Human Development, Design-of-Experiments, Quality-by-Design, Regenerative Medicine, Cell Therapy, and Disease Modeling
Locations
-
Primary
10000 Cedar Avenue
Cleveland, OH 44106, US
Employees at Trailhead Biosystems
-
Ryan Anderson
IBM Architect in Residence, San Francisco; Cambridge University; IBM Technology, Global Industries
-
Michael Bukys
Lead Scientist
-
Angelica M. Gomes Ueltschy, PhD
Director and Scientist | Stem cell differentiation | Empathetic Leader
-
Div Trivedi
Operations, Analytics and Finance at Trailhead Biosystems Inc.
Updates
-
Thank you REPROCELL for featuring Dr Jan Jensen last week's webinar where he discussed control of dopaminergic neuron differentiation using Trailhead Biosystems's proprietary HD-DoE® platform. 👩💻 Missed the event or want to view again? Access the recorded webinar here: https://lnkd.in/dSu8WF7v 🌟 For more information about Trailhead Biosystems and TrailBio Cells visit: https://trailbio.com/ #TrailBio #TrailBioCells #Trailblazing #trailheadbiosystems #hddoe #stemcells #ipsc #ipscs #biotechinnovation #biotech #biotechnology #cellculture #cellbiology #stemcellinnovation #biotechleadership #webinarwednesday
-
Trailhead Biosystems, Inc. (trailbio.com), a biotech company creating iPSC-derived human cells at scale for drug discovery and cell therapy, welcomes Josh Snow, PhD as Chief Commercial Officer. Dr. Snow’s 20 years of combined experience in biotechnology and basic cell biology strategically positions Trailhead Biosystems to deliver market-ready and cGMP solutions for drug discovery and cell therapy. Read the press release: https://lnkd.in/gvr72n7f #TrailBio #TrailBioCells #Trailblazing #trailheadbiosystems #hddoe #stemcells #ipsc #ipscs #biotechinnovation #biotech #biotechnology #cellbiology #stemcellinnovation #biotechleadership
-
Trailhead Biosystems reposted this
Trailhead Biosystems' CEO Dr. Jan Jensen will be presenting at the REPROCELL webinar next week, Sept 19: "BIOLOGY CONTROLLED: High quality iPSC-derived human cells for drug discovery and cell-based therapies." Join the webinar to learn about the latest from TrailBio. Register now! US: https://lnkd.in/gXN6WJVw EMEA: https://lnkd.in/gsFYGXYr #webinarwednesday #webinar #reprocell #TrailBio #TrailBioCells #Trailblazing #trailheadbiosystems #hddoe #stemcells #ipsc #ipscs #biotechinnovation #biotech #biotechnology #cellbiology #stemcellinnovation #biotechleadership
-
Trailhead Biosystems reposted this
Trailhead Biosystems' CEO Dr. Jan Jensen will be presenting at the REPROCELL webinar next week, Sept 19: "BIOLOGY CONTROLLED: High quality iPSC-derived human cells for drug discovery and cell-based therapies." Join the webinar to learn about the latest from TrailBio. Register now! US: https://lnkd.in/gXN6WJVw EMEA: https://lnkd.in/gsFYGXYr #webinarwednesday #webinar #reprocell #TrailBio #TrailBioCells #Trailblazing #trailheadbiosystems #hddoe #stemcells #ipsc #ipscs #biotechinnovation #biotech #biotechnology #cellbiology #stemcellinnovation #biotechleadership
-
Trailhead Biosystems' CEO Dr. Jan Jensen will be presenting at the REPROCELL webinar next week, Sept 19: "BIOLOGY CONTROLLED: High quality iPSC-derived human cells for drug discovery and cell-based therapies." Join the webinar to learn about the latest from TrailBio. Register now! US: https://lnkd.in/gXN6WJVw EMEA: https://lnkd.in/gsFYGXYr #webinarwednesday #webinar #reprocell #TrailBio #TrailBioCells #Trailblazing #trailheadbiosystems #hddoe #stemcells #ipsc #ipscs #biotechinnovation #biotech #biotechnology #cellbiology #stemcellinnovation #biotechleadership
-
Meet the Trailhead Scientists who are attending #ISEH2024 on August 29, 2024! #TrailBio #TrailBioCells #Trailblazing #trailheadbiosystems #hddoe #stemcells #ipsc #ipscs #biotechinnovation #biotech #biotechnology #cellbiology #stemcellinnovation #biotechleadership
-
Enhance your research with Trailhead Biosystem's Custom iPSC Differentiation service. We specialize in converting your iPSCs into the specific cell types required for your projects. Whether for disease modeling, drug screening, or basic research, our tailored approach provides high-quality, physiologically relevant cells to meet your specific needs. For more information on our Custom iPSC Differentiation Service or to discuss your project needs, visit https://lnkd.in/gkEbXXtA #iPSCs #StemCellDifferentiation #CustomCellCulture #Biotechnology #CellBiology #DrugDiscovery #PersonalizedMedicine
-
Soon available for beta testing: iPSC-derived functional hepatocytes. These cells will provide researchers with physiologically relevant human liver models for hepatic disease studies, drug metabolism research, and toxicity screening. In recognition of World Hepatitis Day, we emphasize the potential of these hepatocytes to offer an accessible and reliable alternative to primary human hepatocytes for hepatitis research and drug development. For updates on the availability of our hepatocytes and to participate in beta testing, visit https://lnkd.in/gk5Ws-4W and subscribe to our newsletter. #ComingSoon #Hepatocytes #LiverResearch #StemCells #iPSC #DrugDiscovery #Biotechnology #trailbio #trailbiocells
-
Exciting market insights from Healthcare Industry Updates! We're proud to be a key player in this revolution, transforming how stem cells are differentiated through our HD-DoE™ technology platform. #StemCells #RegenerativeMedicine #BiotechInnovation #Biotech #Biotechnology #Trailbio #Trailbiocells #trailblazing #celltherapy #iPSC #iPSCs #marketgrowth #TrailheadBiosystems
$21.8 billion Stem Cell Manufacturing Market | Size, Share & Trends Download PDF Brochure: https://lnkd.in/d_HFwm-j The global stem cell manufacturing market in terms of revenue was estimated to be worth $12.7 billion in 2023 and is poised to reach $21.8 billion by 2028, growing at a CAGR of 11.3% from 2023 to 2028. 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Lonza Group (Switzerland), Danaher Corporation (US), Sartorius AG (Germany), Becton, Dickinson, and Company (US), Eppendorf AG (Germany), Corning Inc. (US), Bio-Rad Laboratories (US), Takara Bio Group (Japan), Fujifilm Holdings Corporation (Japan), Getinge AB (Sweden), Terumo Corporation (Japan), Bio-Techne Corporation (US), HiMedia Laboratories (India), StemCell Technologies, Inc. (Canada), Miltenyi Biotec GmBH (Germany), PromoCell (Germany), Anterogen Co. Ltd. (South Korea), CellGenix GmBH (India), Pluristem Therapeutics Inc. (Israel), Daiichi Sankyo (Japan), Organogenesis Holdings Inc. (US), Vericel Corporation (US), and American Cryostem Corporation (US). 𝐎𝐭𝐡𝐞𝐫 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐥𝐨𝐛𝐚𝐥𝐥𝐲 RoosterBio Inc. Garuda Therapeutics Gene and Cell Therapy Network Lykan Bioscience - Now RoslinCT PBS Biotech xcellbio Sana Biotechnology, Inc. Cell Culture Technologies Applied StemCell CGT Global Orca Bio Kytopen PeproTech Laurus Bio Trailhead Biosystems TreeFrog Therapeutics CCRM iBET - Instituto de Biologia Experimental e Tecnológica Yashraj Biotechnology Ltd ImmuneBridge InVitria, Inc. RoslinCT StemoniX Mesoblast Limited ESCO ASTER PTE LTD Society for Biological Engineering (SBE-VIT) REPROCELL HemaCare Corporation, a Charles River Company DSS Takara Bio India Pvt Ltd Histocell. Regenerative Medicine NecstGen Pluristyx, Inc. Biotron Healthcare (India) Pvt. Ltd Bonus Biogroup Sartorius CellGenix GmbH VivaBioCell MaaT Pharma Cytovia Therapeutics BioStem Technologies (OTC: BSEM) C3i